COMMUNIQUÉS West-GlobeNewswire

Veradigm™ Supports Cancer Experience Registry With Targeted Outreach Direct to Oncology Healthcare Professionals
05/02/2019
CHICAGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Veradigm ™, an Allscripts (NASDAQ:MDRX), business unit and a leader in providing next-generation healthcare data solutions and systems, is leveraging its capability to [...]
EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP's Breakthrough Focal One® HIFU Technology
05/02/2019
UC I Health , one of the three US medical centers to acquire EDAP's Focal One device, is a recognized leader in prostate cancer diagnosis and treatment utilizing robot-assisted and minimally invasive technologies LYON, [...]
CytomX Therapeutics Announces Senior Management Appointments
05/02/2019
Leadership Team Further Strengthened with Additions of Nick Galli, J.D., as SVP, Chief Business Officer and Leslie Robbins, J.D. as SVP, Intellectual Property SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE [...]
HealthLynked Announces New Mobile Technology to Onboard Patients at Healthcare Provider Locations
05/02/2019
NAPLES, Fla., Feb. 05, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. ( HLYK ) (the “Company”) , a leading digital healthcare business, announced today that it has released new technology to onboard patient members via [...]
Daré Bioscience, Inc. to Present at the 2019 BIO CEO & Investor Conference
05/02/2019
SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule
05/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
Catalyst Biosciences to Present at the Annual BIO CEO & Investor Conference
05/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., (Nasdaq: CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Caladrius Biosciences to Present at Upcoming February Conferences
05/02/2019
BASKING RIDGE, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple technology [...]
Entasis Therapeutics Receives Positive Feedback from FDA End-of-Phase 2 Meeting for ETX2514SUL; Signs Rapid Diagnostic Agreement with bioMérieux
05/02/2019
Entasis to incorporate BIOFIRE® FILMARRAY® System, a rapid molecular diagnostic platform, into ETX2514SUL Phase 3 clinical trial, on track to initiate in 1Q 2019 WALTHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Entasis [...]
GBT Announces New Employment Inducement Grants
05/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on February 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans
05/02/2019
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
05/02/2019
Going Forward, We Will Be Silent Regarding Future Expectations for REMOXY AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today [...]
PCI Biotech: Invitation to fourth quarter and preliminary 2018 result presentation
05/02/2019
Oslo, Norway, 05 February 2019 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report on Wednesday 13 February 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday [...]
BioSig Appoints John Kowalski to Lead Commercialization of PURE EP
05/02/2019
Electrophysiology Industry Veteran to Lead Sales Strategy for the Company’s Novel Cardiac Signal Acquisition and Processing Technology Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
05/02/2019
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
MediPharm Labs Aligns Leadership and Organizational Structure For Future Prosperity of Company
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is pleased to announce the [...]
Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05/02/2019
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition [...]
Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
05/02/2019
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical
05/02/2019
Plans to Increase Presence at Global Interventional Oncology (IO) Medical Conferences CAESAREA, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Following the American Society of Breast Surgeons (ASBrS) Guideline, which were [...]

Pages